What is Proov?
Proov was co-founded by Dr. Amy Beckley, an infertility veteran and PhD Scientist, and Ellen Schell. The company is dedicated to empowering women by providing quick and easy at-home hormone tracking. Dr. Beckley's personal journey through infertility and miscarriages inspired the development of Proov's technology, which aims to help women understand and manage their ovulation quality. Proov's offerings are designed to provide accessible and actionable insights into women's reproductive health, addressing a critical need in the market.
How much funding has Proov raised?
Proov has raised a total of $9.7M across 1 funding round:
Series A
$9.7M
Series A (2021): $9.7M with participation from Portfolia FemTech II Fund, SteelSky Ventures, Hambrecht Ducera Growth Ventures, Lightship Capital, WCC Partners, and Gingerbread Capital
Key Investors in Proov
SteelSky Ventures
SteelSky Ventures is a venture fund focused on investing in companies that enhance access, care, and outcomes in women's health, supporting innovations across consumer health, digital health, and healthcare infrastructure.
Lightship Capital
Lightship Capital invests in founders and entrepreneurs who innovate in U.S. regions, focusing on developing talent and catalyzing emerging ecosystems while believing that impact and profit can coexist.
Gingerbread Capital
Gingerbread Capital is dedicated to closing the funding gap for women-led ventures at early and growth stages, as well as supporting emerging funds led by women and diverse teams.
What's next for Proov?
With the recent infusion of major strategic capital, Proov is poised for significant expansion and product development. The company's focus on empowering women through accessible hormone tracking aligns with the growing demand for personalized health solutions. This investment will likely enable Proov to enhance its existing product line, explore new diagnostic capabilities, and broaden its market reach. The strategic backing from prominent investors suggests a strong belief in Proov's mission and its potential to disrupt the women's health landscape, positioning the company for sustained growth and impact.
See full Proov company page
